登记Id

PA451644

药物名称(英)

thalidomide

通用名称

"N-Phthalimidoglutamic acid imide","N-Phthaloylglutamimide","N-Phthalylglutamic acid imide","Thalidomine USP26","alpha-phthalimidoglutarimide","thalidomide"

商品名称

"Algosediv","Asidon 3","Asmadion","Asmaval","Bonbrain","Bonbrrin","Calmore","Calmorex","Contergan","Corronarobetin","Distaval","Distaxal","Distoval","Ectiluran","Enterosediv","Gastrinide","Glupan","Glutanon","Grippex","Hippuzon","Imida-Lab","Imidan","Imidene","Isomin","Kedavon","Kevadon","Lulamin","Neaufatin","Neo","Neosedyn","Neosydyn","Nerosedyn","Neufatin","Neurodyn","Neurosedin","Neurosedym","Neurosedyn","Nevrodyn","Nibrol","Noctosediv","Noxodyn","Pangul","Pantosediv","Poly-Giron","Polygripan","Predni-Sediv","Pro-ban M","Profarmil","Psycholiquid","Psychotablets","Quetimid","Quietoplex","Sandormin","Sedalis","Sedalis sedi-lab","Sedimide","Sedin","Sedisperil","Sedoval","Shin-naito S","Shinnibrol","Sleepan","Slipro","Softenil","Softenon","Talargan","Talimol","Talismol","Telagan","Telargan","Telargean","Tensival","Thalin","Thalinette","Thalomid","Theophilcholine","Valgis","Valgraine","Yodomin"

品牌组合

类型(英)

Drug

类型

药品

交叉引用

"BindingDB:50070114","Chemical Abstracts Service:50-35-1","ChemSpider:5233","ClinicalTrials.gov:NCT00907452","ClinicalTrials.gov:NCT01782963","DrugBank:DB01041","FDA Drug Label at DailyMed:2eda833b-1357-4ed4-a093-194524fcb061","KEGG Compound:C07910","KEGG Drug:D00754","National Drug Code Directory:59572-205-14","PubChem Compound:5426","PubChem Substance:10112","PubChem Substance:46505665","Therapeutic Targets Database:DAP000865","URL:http://en.wikipedia.org/wiki/Thalidomide"

简化分子线性输入规范

C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O

键

InChI=1S/C13H10N2O4/c16-10-6-5-9(11(17)14-10)15-12(18)7-3-1-2-4-8(7)13(15)19/h1-4,9H,5-6H2,(H,14,16,17)

剂量指南

No

外部词汇

"ATC:L04AX02(thalidomide)","UMLS:C0039736(Thalidomide)","RxNorm:10432(Thalidomide)","NDFRT:N0000148588(THALIDOMIDE)"

RxNorm 标识符

10432

ATC 标识符

L04AX02

化合物标识符

5426